Glen R. Elliott, PhD, MD
Dr. Elliott diagnoses and treats severe psychiatric disorders in children and adolescents. An internationally known expert in psychoactive medications, he is the author of Medicating Young Minds: How to Know if Psychiatric Drugs Will Help or Hurt Your Child. Before joining Children’s Health Council, Dr. Elliott was Director of the Children’s Center at Langley Porter Psychiatric Institute, University of California, San Francisco for over 17 years. He also is Associate Training Director for the Stanford Child and Adolescent Psychiatry residency programs.
In his off time, Dr. Elliott is a 25-year Board Member for Camp Opportunity, an organization that provides summer camp experiences for Santa Cruz County foster children to help build self-esteem. He also directs a three-octave bell choir at his church.
- MD, Stanford School of Medicine
- PhD, Neuro- and Biobehavioral Sciences, Stanford School of Medicine
- Psychiatry Intern, Stanford School of Medicine
- Visiting Fellow, Institute of Medicine, National Academy of Sciences
- Macy Fellow, Harvard University, Health Policy
- MacArthur Fellow, Harvard University, Mental Health Research
- General Psychiatry Resident, McLean Hospital, Harvard School of Medicine
- Child and Adolescent Psychiatry Resident, Stanford School of Medicine
- BS, Chemistry, Michigan State University
- California Medical License
- American Board of Psychiatry and Neurology (Psychiatry)
- American Board of Psychiatry and Neurology (Child and Adolescent Psychiatry)
- University of California, San Francisco, Emeritus Professor of Clinical Psychiatry
- Stanford School of Medicine, Clinical Professor (Affiliated) Psychiatry
- Listed in Best Doctors of America
- Recognition for service from The American Board of Psychiatry and Neurology
- Teaching Award from Child and Adolescent Psychiatry at Stanford
- Teaching Award from General Psychiatry Residents at University of California, San Francisco
- UCSF Chancellor’s Award for Community Service
- Dr. Elliott gives regular presentations through CHC’s parent education program and for organizations throughout the Bay Area on topics related to medication use for behavioral and psychiatric problems in children and adolescents, autism, bipolar disorder and ADHD.
- Elliott, G.R., with Kelly, K. Medicating Young Minds: How to Know If Psychiatric Drugs Will Help or Hurt Your Child. New York: Stewart, Tabori & Chang, (2006).
- Molina, B.S., Hinshaw, S.P., Swanson, J.M., Arnold, L.E., Vitiello, B., Jensen, P.S., Epstein, J.N., Hoza, B., Hechtman, L., Abikoff, H.B., Elliott, G.R., Greenhill, L.L., Newcorn, J.H., Wells, K.C., Wigal, T., Gibbons, R.D., Hur, K., Houck, P.R. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry 48:484-500, 2009.
- Klaiman, C., Huffman, L., Masaki, L., Elliott, G.R. Sapropterin as a treatment for Autism Spectrum Disorders: a double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology 23:320-328, (2013).
- Elliott, G.R., Blasey, C., Rekshan, W., Rush, A.J., Palmer, D.M., Clarke, S., Kohn, M., Kaplan, C., Gordon, E. Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate. Journal of Attention Disorders Epublication August 2014.